The weekly litigation news digest is live. Subscribe now

Pharmaceutical Composition Of S-Ketamine Hydrochloride - EP2968221

The patent EP2968221 was granted to Janssen Pharmaceutica on Jun 19, 2019. The application was originally filed on Mar 14, 2014 under application number EP14719471A. The patent is currently recorded with a legal status of "Revoked".

EP2968221

JANSSEN PHARMACEUTICA
Application Number
EP14719471A
Filing Date
Mar 14, 2014
Status
Revoked
May 7, 2021
Publication Date
Jun 19, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ASPIRE PHARMAMar 18, 2020BROWNADMISSIBLE
SANDOZMar 17, 2020ELKINGTON AND FIFEADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONWO2014031975
INTERNATIONAL-SEARCH-REPORTDE102007009888
INTERNATIONAL-SEARCH-REPORTWO2007111880
INTERNATIONAL-SEARCH-REPORTWO9423711
OPPOSITIONDE102007009888
OPPOSITIONWO0234293
OPPOSITIONWO2007111880
OPPOSITIONWO2014031975
OPPOSITIONWO9423711

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents